Bharat Cancer Genome Grid (BCG2)

The Bharat Cancer Genome Grid is a clinician-centric national initiative designed to accelerate the responsible adoption of Whole Genome Sequencing (WGS) in routine oncology practice. Conceived as the clinical translation arm of the Bharat Cancer Genome Atlas (BCGA), BCG2 empowers oncologists with the frameworks, expertise, and collaborative platforms required to turn genomic data into meaningful patient care decisions.

Why BCG2

Over the last decade, oncology has shifted from anatomical classification to molecularly informed care. While genomic data generation in India has grown rapidly, the clinical systems needed to interpret and apply WGS findings in Oncology remain fragmented.

This gap means genomic reports are underutilized or misunderstood, oncologists lack standardized interpretation support, and Indian genomic insights are not fully translated into treatment decisions. BCG2 exists to close this gap by enabling clinicians to use emerging evidence and genomic knowledge confidently and consistently.

Built on the Foundation of the Bharat Cancer Genome Atlas

BCG2 is a natural extension of the Bharat Cancer Genome Atlas, a pioneering initiative by Indian Institute of Technology Madras and Karkinos Healthcare.

While BCGA is the national repository of Indian cancer genomes, BCG2 enables clinical translation of this genomic knowledge into oncology practice. Together, they form a discovery → validation → clinical care ecosystem.

What BCG2 Enables for Clinicians

BCG2 equips oncologists to move from passive recipients of genomic reports to active interpreters of WGS data. BCG2 enables harmonized evidence frameworks for application of genomics in oncology along with structured genomics education and continuous peer-to-peer learning.

A key component of BCG2 is the establishment of multi-institutional molecular tumor boards.

Invitation to Oncologists — Join the Bharat Cancer Genome Grid

The Bharat Cancer Genome Grid invites oncologists, hematologists, clinician-scientists, and genomics researchers across India to shape the future of genomics-enabled cancer care.

Participants help define national standards, discuss complex cases, co-develop interpretation frameworks, and build evidence reflecting the unique genomic landscape of Indian patients.

Register Here